On the Sputnik Covid-19 vaccine produced by Russia, Khairy said that Duopharma Biotech Bhd’s wholly-owned subsidiary, Duopharma (M) Sdn Bhd (DMSB), which holds the distribution rights to the product, has three months to register the vaccine with the National Pharmaceutical Regulatory Agency (NPRA), after inking an agreement with the government earlier this month.
He said that the NPRA still requires further information on the vaccine.
“However, NPRA also said that it would simplify the registration process if Sputnik gets emergency use (status) from the World Health Organisation (WHO). Sputnik has not received the EUL from WHO yet,” he said, referring to the Emergency Use Listing.
Nigeria has become the 68th country in the world to approve the Sputnik V. Total population of all countries where Sputnik V is approved for use now exceeds 3.7 billion people, which is nearly half of the global population.
CHINESE BUSINESSMEN,STUDENTS etc very LOYAL to SINOPHARM ...when SINOPHARM open to private n goverment sectors...telephones ring non stop in private clinics...the sound of KA CHING...KA CHING...KA CHING...IT IS HAPPENNING IN SINGAPORE...
The Board of Directors of Kanger (“Company”) wishes to announce that Kanger Medical International Sdn. Bhd., a wholly-owned subsidiary of the Company had, on 19 July 2021 entered into Head of Agreement with Sparmak Medical Equipment Trading LLC for purchase of inactivated SARS-COV-2 Vaccines (Vero Cell) vaccine developed by Beijing Institute of Biological Products Co. Ltd., an affiliate of SINOPHARM CNBG.
Please refer to the full announcement as attached.
Heard that some internal people mentioning that KANGER previously build connection in Sabah and Sarawak and now they will working together with DUOPHARMA to distribute sinopharm to supply for Malaysia
Is Dparma being used as "second fiddle" again after playing the Sputnik V prop up man? Sputnik V had been dragged for miles and NPRA approval depends on WHO, whom are..hhmmm..
Dpharma, is said to be Registered Holder of Sinopharm, but Kanger has placed an order for 5 million doses ahead of Dpharma? Sinopharm is imported prepacked, and no FnF is necessary?
Secondly, Sinopharm is to be distributed to Private sectors and not used in NIP as with Pfizer and AZ?
useless company, vaccine got approval pun cannot make money.. look at pharma, can produce 14 million doses faster supply 4 months in advance and also can sell to other countries.
according to latest health expert report...booster shots are required every 6 months...biotech is worth usd750 billion...will be worth usd 1 TRILLION or more...astronomical...
It's totally unbelievable at this moment and point in time of NIP roll-out that people still harbor the wishful thinking of Sputnik V landing in Malaysia, albeit missing the most crucial impacting moment.
Now with the Sinopharm Registered Holdership in hand, pray tell, what and when did you see or read any PROGRESS??????? It's all wayang, my friends, and you are all the SUCKERS!!!
WHO regional director for europe HANS KLUGE said 'there are definitely grounds for optomism on the prospect of SPUTNIK V's approval by WHO' ...HUNGARY EU MEMMBER granted emergency use authorization for SPUTNIK V...awesome...SPUTNIK V...
according to latest health expert report...booster shots are required every 6 months...biotech is worth usd 750 billion...will be worth usd 1 TRILLION...astronomical...
TQ for the info...Ron90...after 2 shots of vaccines only can give protection against the DELTA VARIANT COVID VIRUS...1 shot of vaccine can only give minimum protection...
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
Report Abuse
Please Sign In to report this post as abuse.
Market Buzz
No result.
Featured Posts
MQ Trader
Introducing MY's First IPO Fund for Sophisticated Investors!
MQ Chat
New Update. Discover investment communities that resonate with your ideas
MQ Trader
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
0:17
New IPO: Carlo Rino Group Berhad, a leading fashion retailer of women’s handbags, footwear, and accessories, aims to list on the ACE Market!
MQ Trader 130 views | 22 h ago
0:17
New IPO: A homegrown air fragrance company, Vanzo Holdings Berhad aims to list on the Ace Market!
MQ Trader 236 views | 1 d ago
0:17
New IPO: Winstar Capital Berhad, a specialist in the extrusion of aluminium profiles and fabrication of aluminium ladders aims to list on the ACE Market!
MQ Trader 405 views | 2 d ago
0:17
New IPO: Topvision Eye Specialist Berhad, specializing in medical eye care services aims to list on the ACE Market!
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
MZM2511
4,553 posts
Posted by MZM2511 > 2021-07-17 14:56 | Report Abuse
On the Sputnik Covid-19 vaccine produced by Russia, Khairy said that Duopharma Biotech Bhd’s wholly-owned subsidiary, Duopharma (M) Sdn Bhd (DMSB), which holds the distribution rights to the product, has three months to register the vaccine with the National Pharmaceutical Regulatory Agency (NPRA), after inking an agreement with the government earlier this month.
He said that the NPRA still requires further information on the vaccine.
“However, NPRA also said that it would simplify the registration process if Sputnik gets emergency use (status) from the World Health Organisation (WHO). Sputnik has not received the EUL from WHO yet,” he said, referring to the Emergency Use Listing.
Source: https://www.malaymail.com/news/malaysia/2021/06/21/khairy-cansino-vaccine-to-arrive-in-malaysia-next-month-no-updates-yet-on-j/1983852